Annual ROE
2.09%
-2.89%-58.03%
March 31, 2024
Summary
- As of February 7, 2025, TAK annual return on equity is 2.09%, with the most recent change of -2.89% (-58.03%) on March 31, 2024.
- During the last 3 years, TAK annual ROE has fallen by -5.73% (-73.27%).
- TAK annual ROE is now -88.78% below its all-time high of 18.63%, reached on March 31, 2003.
Performance
TAK ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
2.85%
-1.16%-28.93%
December 1, 2024
Summary
- As of February 7, 2025, TAK quarterly return on equity is 2.85%, with the most recent change of -1.16% (-28.93%) on December 1, 2024.
- Over the past year, TAK quarterly ROE has dropped by -1.16% (-28.93%).
- TAK quarterly ROE is now -83.39% below its all-time high of 17.16%, reached on June 30, 2009.
Performance
TAK Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
TAK ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -58.0% | -28.9% |
| 3 y3 years | -73.3% | -42.9% |
| 5 y5 years | -43.7% | -64.2% |
TAK ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -73.3% | at low | -67.1% | +40.4% |
| 5 y | 5-year | -73.3% | +132.2% | -70.2% | +763.6% |
| alltime | all time | -88.8% | +133.8% | -83.4% | +144.1% |
Takeda Pharmaceutical Company Limited ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | 2.85%(-28.9%) |
| Sep 2024 | - | 4.01%(+97.5%) |
| Jun 2024 | - | 2.03%(-4.7%) |
| Mar 2024 | 2.09%(-58.0%) | 2.13%(-20.2%) |
| Dec 2023 | - | 2.67%(-9.8%) |
| Sep 2023 | - | 2.96%(-36.1%) |
| Jun 2023 | - | 4.63%(-7.2%) |
| Mar 2023 | 4.98%(+13.7%) | 4.99%(+15.8%) |
| Dec 2022 | - | 4.31%(+20.4%) |
| Sep 2022 | - | 3.58%(+2.3%) |
| Jun 2022 | - | 3.50%(-21.2%) |
| Mar 2022 | 4.38%(-44.0%) | 4.44%(-48.8%) |
| Dec 2021 | - | 8.67%(-9.4%) |
| Sep 2021 | - | 9.57%(+7.5%) |
| Jun 2021 | - | 8.90%(+11.9%) |
| Mar 2021 | 7.82%(+768.9%) | 7.95%(+106.5%) |
| Dec 2020 | - | 3.85%(+226.3%) |
| Sep 2020 | - | 1.18%(-53.0%) |
| Jun 2020 | - | 2.51%(+172.8%) |
| Mar 2020 | 0.90%(-75.7%) | 0.92%(+178.8%) |
| Dec 2019 | - | 0.33%(-84.9%) |
| Sep 2019 | - | 2.19%(+14.7%) |
| Jun 2019 | - | 1.91%(-61.8%) |
| Mar 2019 | 3.71%(-59.9%) | 5.00%(-4.8%) |
| Dec 2018 | - | 5.25%(-21.1%) |
| Sep 2018 | - | 6.65%(+15.7%) |
| Jun 2018 | - | 5.75%(-36.1%) |
| Mar 2018 | 9.26%(+53.8%) | 9.00%(-4.6%) |
| Dec 2017 | - | 9.43%(+14.6%) |
| Sep 2017 | - | 8.23%(+0.1%) |
| Jun 2017 | - | 8.22%(+34.3%) |
| Mar 2017 | 6.02%(+63.6%) | 6.12%(-11.8%) |
| Dec 2016 | - | 6.94%(-7.3%) |
| Sep 2016 | - | 7.49%(-0.7%) |
| Jun 2016 | - | 7.54%(+112.4%) |
| Mar 2016 | 3.68% | 3.55%(-169.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | - | -5.08%(-21.5%) |
| Sep 2015 | - | -6.47%(+8.2%) |
| Jun 2015 | - | -5.98%(+17.9%) |
| Mar 2015 | -6.19%(-244.0%) | -5.07%(-338.0%) |
| Dec 2014 | - | 2.13%(-42.3%) |
| Sep 2014 | - | 3.69%(-15.6%) |
| Jun 2014 | - | 4.37%(-2.9%) |
| Mar 2014 | 4.30%(-38.8%) | 4.50%(-25.2%) |
| Dec 2013 | - | 6.02%(+29.2%) |
| Sep 2013 | - | 4.66%(+2.6%) |
| Jun 2013 | - | 4.54%(-38.0%) |
| Mar 2013 | 7.03%(+16.2%) | 7.32%(+45.0%) |
| Dec 2012 | - | 5.05%(-5.1%) |
| Sep 2012 | - | 5.32%(-20.5%) |
| Jun 2012 | - | 6.69%(+11.7%) |
| Mar 2012 | 6.05%(-48.7%) | 5.99%(-35.7%) |
| Dec 2011 | - | 9.32%(-18.4%) |
| Sep 2011 | - | 11.42%(-7.4%) |
| Jun 2011 | - | 12.33%(+5.4%) |
| Mar 2011 | 11.79%(-19.4%) | 11.70%(-3.5%) |
| Dec 2010 | - | 12.13%(+1.1%) |
| Sep 2010 | - | 12.00%(0.0%) |
| Jun 2010 | - | 12.00%(-16.3%) |
| Mar 2010 | 14.62%(+36.4%) | 14.33%(-9.1%) |
| Dec 2009 | - | 15.76%(-7.4%) |
| Sep 2009 | - | 17.02%(-0.8%) |
| Jun 2009 | - | 17.16%(+49.0%) |
| Mar 2009 | 10.72%(-24.2%) | 11.52%(+43.6%) |
| Dec 2008 | - | 8.02% |
| Mar 2008 | 14.14%(+0.4%) | - |
| Mar 2007 | 14.08%(-1.9%) | - |
| Mar 2006 | 14.35%(-0.8%) | - |
| Mar 2005 | 14.46%(-13.2%) | - |
| Mar 2004 | 16.66%(-10.6%) | - |
| Mar 2003 | 18.63%(+1.6%) | - |
| Mar 2002 | 18.33%(+32.4%) | - |
| Mar 2001 | 13.84% | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual return on equity?
- What is the all time high annual ROE for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual ROE year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly return on equity?
- What is the all time high quarterly ROE for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly ROE year-on-year change?
What is Takeda Pharmaceutical Company Limited annual return on equity?
The current annual ROE of TAK is 2.09%
What is the all time high annual ROE for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual return on equity is 18.63%
What is Takeda Pharmaceutical Company Limited annual ROE year-on-year change?
Over the past year, TAK annual return on equity has changed by -2.89% (-58.03%)
What is Takeda Pharmaceutical Company Limited quarterly return on equity?
The current quarterly ROE of TAK is 2.85%
What is the all time high quarterly ROE for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly return on equity is 17.16%
What is Takeda Pharmaceutical Company Limited quarterly ROE year-on-year change?
Over the past year, TAK quarterly return on equity has changed by -1.16% (-28.93%)